BioCentury’s Back to School 2026: The global first-in-human race, examines Korea’s growing potential in early-stage clinical development — from its clinical infrastructure and advanced-therapy capabilities to its regulatory environment.
Jurie Hwang of KoreaBIO was interviewed for the article's coverage of Korea's clinical development landscape!
What gives Korea an edge, and what still needs to change?
| 
